Respiratory diseases are the third most common cause of death and the second most common cause of hospital admissions in the UK, yet effective treatments are lacking.
Our research helps to reduce disease progression and symptoms for those with respiratory conditions.
We are working towards earlier diagnosis and more targeted approach, which match an individual to the treatment most likely to provide the desired response.
Manchester University NHS Foundation Trust’s (MFT’s) Wythenshawe Hospital hosts the largest clinical respiratory department in the UK, delivering care to population with often poor health outcomes and high levels of deprivation through specialist regional and national clinics, several of them with world-leading expertise.
Wythenshawe Hospital has world leading expertise in clinical trials, particularly in asthma, COPD and cough. Th site hosts the innovative Salford Lung Study, which is the first randomised controlled study to assess the clinical effectiveness of a pre-licensed medication in asthma and COPD in a real-world study. The study used an electronic patient record with complex informatics support from NWeHealth. At the site this is also the only charity-owned respiratory trial facility in the UK, the Medicines Evaluation Unit.